Kaposi Sarcoma clinical trials
16 active trials name this condition. Describe your situation to see which ones you may be eligible for.
Refine by biomarker
By location
- Recombinant Glycosylated Human Interleukin-7 (CYT107) for the Treatment of Kaposi Sarcoma in Participants With HIV and Immune Non-Response (REGIMENKS HIV)
- PDS01ADC Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma
- Propranolol for the Treatment of Kaposi Sarcoma in Adults
- Trial of Ixazomib for Kaposi Sarcoma
- Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma
- Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIV
- A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
- Precision Imaging to Evaluate Kaposi Sarcoma (PRIME-KS): A Device Feasibility Trial
- Natural History Study of Kaposi Sarcoma
- Natural History of KSHV-Associated Multicentric Castleman s Disease
- Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
- Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman Disease
- Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target
- Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
- Nirogacestat in Patients With Kaposi Sarcoma
- A Study of sEphB4-HSA in Kaposi Sarcoma
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Kaposi Sarcoma” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.